Grade My Investments
HomeFree Stock Grades › PSNL

Personalis, Inc. (PSNL) Stock Grade

PSNL · Healthcare

C+
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$710.4M
P/E Ratio
Revenue Growth (YoY)
-100.0%
Net Margin
0.0%
Return on Equity
Dividend Yield
None

About Personalis, Inc.'s fundamentals

Personalis is a healthcare diagnostics company with a market capitalization of $710.4 million that reported a net loss in its latest annual statement, resulting in a net margin of 0.0% and no dividend payments. The company experienced a dramatic revenue decline of -100.0% year-over-year, indicating a significant contraction in business operations. With a net loss position and negative revenue trajectory, the company currently lacks profitability metrics such as a meaningful P/E ratio or measurable return on equity.

Track PSNL free — no credit card required. Live grade + monthly AI report →